FGEN

FibroGen News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.77 5.25% 35.50 19:51:45
Open Price Low Price High Price Close Price Prev Close
33.73 33.28 35.67 35.66 33.73
more quote information »

Recent News

Date Time Source Heading
3/02/202109:28SEEKFibroGen shares plummet 24% as FDA meeting, Jefferies..
3/01/202116:12SEEKFibroGen EPS misses by $0.38, misses on revenue
3/01/202116:07EDGARCurrent Report Filing (8-k)
3/01/202116:01GLOBEFibroGen Provides Regulatory Update on Roxadustat
2/28/202117:35SEEKFibroGen Q4 2020 Earnings Preview
2/18/202107:00GLOBEFibroGen to Report Fourth Quarter and Full Year 2020..
2/12/202107:00GLOBEFibroGen to Present at Upcoming Investor Conferences
2/10/202110:59EDGARAmended Statement of Ownership (sc 13g/a)
2/08/202110:22EDGARAmended Statement of Ownership (sc 13g/a)
1/29/202110:01EDGARAmended Statement of Ownership (sc 13g/a)
1/27/202106:00EDGARCurrent Report Filing (8-k)
1/07/202110:04EDGARAmended Statement of Ownership (sc 13g/a)
12/30/202018:08EDGARStatement of Changes in Beneficial Ownership (4)
12/22/202007:00GLOBEFibroGen Advances Phase 3 Clinical Development of..
12/21/202012:25DJNFibroGen Down; FDA Extends Review Period for Roxadustat
12/18/202017:11EDGARCurrent Report Filing (8-k)
12/18/202016:59GLOBEFibroGen Provides Regulatory Update on Roxadustat
12/03/202018:51EDGARStatement of Changes in Beneficial Ownership (4)
12/03/202018:42EDGARInitial Statement of Beneficial Ownership (3)
12/02/202007:00GLOBEFibroGen to Present Safety and Efficacy Analyses from..
12/01/202008:06EDGARCurrent Report Filing (8-k)
12/01/202008:00GLOBEFibroGen Announces Retirement of K. Peony Yu, M.D., and..
11/27/202007:00GLOBEAstellas Receives Approval of EVRENZO® (roxadustat) in Japan..
11/27/202002:02PRNUSAstellas Receives Approval of EVRENZO® (roxadustat) in Japan..
11/19/202016:52EDGARStatement of Changes in Beneficial Ownership (4)
11/12/202016:47EDGARCurrent Report Filing (8-k)
11/06/202007:00GLOBEFibroGen to Present at Upcoming Investor Conferences
11/05/202016:15EDGARQuarterly Report (10-q)
11/05/202016:08EDGARCurrent Report Filing (8-k)
11/05/202016:01GLOBEFibroGen Reports Third Quarter 2020 Financial Results
10/29/202007:00GLOBEFibroGen to Report Third Quarter 2020 Financial Results
10/22/202010:08GLOBEFibroGen Presents Late-Breaker Abstract Results on..
10/14/202007:00GLOBEFibroGen to Present New Efficacy and Safety Analyses from..
10/02/202007:00PRNUSNew Ventures Funds Rebrands as Scientia Ventures
9/18/202017:19EDGARStatement of Changes in Beneficial Ownership (4)
9/17/202018:04EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:36EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:33EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:30EDGARStatement of Changes in Beneficial Ownership (4)
9/10/202019:28EDGARStatement of Changes in Beneficial Ownership (4)
9/08/202007:00GLOBEFibroGen Appoints Percy Carter, MBA, PhD, as Chief..
9/04/202016:34EDGARStatement of Changes in Beneficial Ownership (4)
9/04/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
9/01/202007:00GLOBEFibroGen to Present at Upcoming Investor Conferences
8/21/202017:59EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202016:35EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202007:00GLOBEFibroGen Announces First Patient Enrolled in Pamrevlumab..
8/07/202019:50EDGARStatement of Changes in Beneficial Ownership (4)
8/07/202019:46EDGARStatement of Changes in Beneficial Ownership (4)
8/07/202019:26EDGARInitial Statement of Beneficial Ownership (3)
See more news about this stock »
Your Recent History
NASDAQ
FGEN
FibroGen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210306 02:04:18